Clinical Trial Update: Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Papillon+TM per-operative radiotherapy for localized breast cancer is currently recruiting at Centre Antoine Lacassagne.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Centre Antoine Lacassagne | Conditions: Localized Breast Cancer | Phase 2 | Status: RECRUITING